Melanocortin receptor accessory proteins in adrenal disease and obesity

Frontiers in Neuroscience

Volumn 9, Issue MAY, 2015, Pages

  Jackson, David S ^a   Ramachandrappa, Shwetha ^a   Clark, Adrian J ^a   Chan, Li F ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Accessory proteins; Adrenal function; Knockout mouse model; Melanocortin receptors; Obesity

Indexed keywords

MELANOCORTIN 2 RECEPTOR; MELANOCORTIN 4 RECEPTOR; MELANOCORTIN RECEPTOR; MELANOCORTIN RECEPTOR ACCESSORY PROTEIN; MELANOCORTIN RECEPTOR ACCESSORY PROTEIN 2; PROTEIN; PROTEIN VARIANT; UNCLASSIFIED DRUG;

ADRENAL DISEASE; ARTICLE; BODY WEIGHT; DISEASE SEVERITY; ENERGY EXPENDITURE; FAMILIAL GLUCOCORTICOID DEFICIENCY TYPE 2; FOOD INTAKE; GENE DELETION; HETEROZYGOSITY; HORMONE DEFICIENCY; HUMAN; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; HYPOTHALAMUS; IN VITRO STUDY; KNOCKOUT MOUSE; MAMMAL; NONHUMAN; OBESITY; ONSET AGE; PARALOGY; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

EID: 84930634349     PISSN: 16624548     EISSN: 1662453X     Source Type: Journal    
DOI: 10.3389/fnins.2015.00213     Document Type: Article

References (86)

1. R.M. Dores, Observations on the evolution of the melanocortin receptor gene family: distinctive features of the melanocortin-2 receptor. Front Neurosci 7 (2013) 28.
2. Y. Yang, Structure, function and regulation of the melanocortin receptors. Eur J Pharmacol 660 (2011) 125-30.
3. W.A. Nijenhuis, J. Oosterom, and R.A. Adan, AgRP(83-132) acts as an inverse agonist on the human-melanocortin-4 receptor. Mol Endocrinol 15 (2001) 164-71.
4. A. Breit, T.R. Buch, I. Boekhoff, H.J. Solinski, E. Damm, and T. Gudermann, Alternative G protein coupling and biased agonism: new insights into melanocortin-4 receptor signalling. Mol Cell Endocrinol 331 (2011) 232-40.
5. L.E. Pritchard, A.V. Turnbull, and A. White, Pro-opiomelanocortin processing in the hypothalamus: impact on melanocortin signalling and obesity. J Endocrinol 172 (2002) 411-21.
6. R.D. Cone, Studies on the physiological functions of the melanocortin system. Endocr Rev 27 (2006) 736-49.
7. D. Lu, D. Willard, I.R. Patel, S. Kadwell, L. Overton, T. Kost, M. Luther, W. Chen, R.P. Woychik, W.O. Wilkison, et al., Agouti protein is an antagonist of the melanocyte-stimulatinghormone receptor. Nature 371 (1994) 799-802.
8. M.M. Ollmann, B.D. Wilson, Y.K. Yang, J.A. Kerns, Y. Chen, I. Gantz, and G.S. Barsh, Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 278(1997)135-8.
9. J.R. Shutter, M. Graham, A.C. Kinsey, S. Scully, R. Luthy, and K.L. Stark, Hypothalamic expression of ART, a novel gene related to agouti, is up-regulated in obese and diabetic mutant mice. Genes Dev 11 (1997) 593-602.
10. D.I. Vage, D. Lu, H. Klungland, S. Lien, S. Adalsteinsson, and R.D. Cone, A non-epistatic interaction of agouti and extension in the fox, Vulpes vulpes. Nat Genet 15 (1997) 311-5.
11. B.X. Chai, R.R. Neubig, G.L. Millhauser, D.A. Thompson, P.J. Jackson, G.S. Barsh, C.J. Dickinson, J.Y. Li, Y.M. Lai, and I. Gantz, Inverse agonist activity of agouti and agouti-related protein. Peptides 24 (2003) 603-9.
12. X.L. Mo, and Y.X. Tao, Activation of MAPK by inverse agonists in six naturally occurring constitutively active mutant human melanocortin-4 receptors. Biochim Biophys Acta 1832 (2013) 1939-48.
13. K.A. Beaumont, D.J. Smit, Y.Y. Liu, E. Chai, M.P. Patel, G.L Millhauser, J.J. Smith, P.F. Alewood, and R.A. Sturm, Melanocortin-1 receptor-mediated signalling pathways activated by NDPMSH and HBD3 ligands. Pigment Cell Melanoma Res 25 (2012) 370-4.
14. V.B. Swope, J.A. Jameson, K.L. McFarland, D.M. Supp, W.E. Miller, D.W. McGraw, M.A. Patel, M.A. Nix, G.L. Millhauser, G.F. Babcock, and Z.A. Abdel-Malek, Defining MC1R regulation in human melanocytes by its agonist alpha-melanocortin and antagonists agouti signaling protein and beta-defensin 3. J Invest Dermatol 132 (2012) 2255-62.
15. L. He, T.M. Gunn, D.M. Bouley, X.Y. Lu, S.J. Watson, S.F. Schlossman, J.S. Duke-Cohan, and G.S. Barsh, A biochemical function for attractin in agouti-induced pigmentation and obesity. Nat Genet 27 (2001) 40-7.
16. K.A. Beaumont, S.S. Wong, S.A. Ainger, Y.Y. Liu, M.P. Patel, G.L. Millhauser, J.J. Smith, P.F. Alewood, J.H. Leonard, and R.A. Sturm, Melanocortin MC(1) receptor in human genetics and model systems. Eur J Pharmacol 660 (2011) 103-10.
17. A. Catania, S. Gatti, G. Colombo, and J.M. Lipton, Targeting melanocortin receptors as a novel strategy to control inflammation. Pharmacol Rev 56 (2004) 1-29.
18. R.A. Star, N. Rajora, J. Huang, R.C. Stock, A. Catania, and J.M. Lipton, Evidence of autocrine modulation of macrophage nitric oxide synthase by alpha-melanocyte-stimulating hormone. Proc Natl Acad Sci U S A 92 (1995) 8016-20.
19. A.J. Clark, L. McLoughlin, and A. Grossman, Familial glucocorticoid deficiency associated with point mutation in the adrenocorticotropin receptor. Lancet 341 (1993) 461-2.
20. D. Chida, S. Nakagawa, S. Nagai, H. Sagara, H. Katsumata, T. Imaki, H. Suzuki, F. Mitani, T. Ogishima, C. Shimizu, H. Kotaki, S. Kakuta, K. Sudo, T. Koike, M. Kubo, and Y. Iwakura, Melanocortin 2 receptor is required for adrenal gland development, steroidogenesis, and neonatal gluconeogenesis. Proc Natl Acad Sci U S A 104 (2007) 18205-10.
21. Q. Zhong, S. Sridhar, L. Ruan, K.H. Ding, D. Xie, K. Insogna, B. Kang, J. Xu, R.J. Bollag, and C M. Isales, Multiple melanocortin receptors are expressed in bone cells. Bone 36 (2005) 820-31.
22. L.L. Elias, A. Huebner, L.A. Metherell, A. Canas, G.L. Warne, M.L. Bitti, S. Cianfarani, P.E. Clayton, M.O. Savage, and A.J. Clark, Tall stature in familial glucocorticoid deficiency. Clin Endocrinol (Oxf) 53 (2000) 423-30.
23. S.R. Smith, B. Gawronska-Kozak, L. Janderova, T. Nguyen, A. Murrell, J.M. Stephens, and R.L. Mynatt, Agouti expression in human adipose tissue: functional consequences and increased expression in type 2 diabetes. Diabetes 52 (2003) 2914-22.
24. P.J. O'Shaughnessy, P.J. Baker, A. Monteiro, S. Cassie, S. Bhattacharya, and P.A. Fowler, Developmental changes in human fetal testicular cell numbers and messenger ribonucleic acid levels during the second trimester. J Clin Endocrinol Metab 92 (2007) 4792-801.
25. C.L. Moller, K. Raun, M.L. Jacobsen, T.A. Pedersen, B. Holst, K.W. Conde-Frieboes, and B.S. Wulff, Characterization of murine melanocortin receptors mediating adipocyte lipolysis and examination of signalling pathways involved. Mol Cell Endocrinol 341 (2011) 9-17.
26. G.M. Sutton, K. Begriche, K.G. Kumar, J.M. Gimble, D. Perez-Tilve, R. Nogueiras, R.P. McMillan, M.W. Hulver, M.H. Tschop, and A.A. Butler, Central nervous system melanocortin-3 receptors are required for synchronizing metabolism during entrainment to restricted feeding during the light cycle. Faseb J 24 (2010) 862-72.
27. G.M. Sutton, D. Perez-Tilve, R. Nogueiras, J. Fang, J.K. Kim, R.D. Cone, J.M. Gimble, M.H. Tschop, and A.A. Butler, The melanocortin-3 receptor is required for entrainment to meal intake. J Neurosci 28 (2008) 12946-55.
28. K. Begriche, P.R. Levasseur, J. Zhang, J. Rossi, D. Skorupa, L.A. Solt, B. Young, T.P. Burris, D.L. Marks, R.L. Mynatt, and A.A. Butler, Genetic dissection of the functions of the melanocortin-3 receptor, a seven-transmembrane G-protein-coupled receptor, suggests roles for central and peripheral receptors in energy homeostasis. J Biol Chem 286 (2011) 40771-81.
29. Y.S. Lee, L.K. Poh, B.L. Kek, and K.Y. Loke, The role of melanocortin 3 receptor gene in childhood obesity. Diabetes 56 (2007) 2622-30.
30. M. Mencarelli, B. Dubern, R. Alili, S. Maestrini, L. Benajiba, M. Tagliaferri, P. Galan, M. Rinaldi, C. Simon, P. Tounian, S. Hercberg, A. Liuzzi, A.M. Di Blasio, and K. Clement, Rare melanocortin-3 receptor mutations with in vitro functional consequences are associated with human obesity. Hum Mol Genet 20 (2011) 392-9.
31. K. Begriche, O.J. Marston, J. Rossi, L.K. Burke, P. McDonald, L.K. Heisler, and A.A. Butler, Melanocortin-3 receptors are involved in adaptation to restricted feeding. Genes Brain Behav 11 (2012) 291-302.
32. T. Montero-Melendez, M.F. Madeira, L.V. Norling, A. Alsam, M.A. Curtis, T.A. da Silva, and M. Perretti, Association between periodontal disease and inflammatory arthritis reveals modulatory functions by melanocortin receptor type 3. Am J Pathol 184 (2014) 2333-41.
33. S.J. Getting, C.W. Lam, G. Leoni, F.N. Gavins, P. Grieco, and M. Perretti, [D-Trp8]-gammamelanocyte-stimulating hormone exhibits anti-inflammatory efficacy in mice bearing a nonfunctional MC1R (recessive yellow e/e mouse). Mol Pharmacol 70 (2006) 1850-5.
34. G. Leoni, H.B. Patel, A.L. Sampaio, F.N. Gavins, J.F. Murray, P. Grieco, S.J. Getting, and M. Perretti, Inflamed phenotype of the mesenteric microcirculation of melanocortin type 3 receptor-null mice after ischemia-reperfusion. Faseb J 22 (2008) 4228-38.
35. D. Huszar, C.A. Lynch, V. Fairchild-Huntress, J.H. Dunmore, Q. Fang, L.R. Berkemeier, W. Gu, R.A. Kesterson, B.A. Boston, R.D. Cone, F.J. Smith, L.A. Campfield, P. Burn, and F. Lee, Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88 (1997)131-41.
36. N. Balthasar, L.T. Dalgaard, C.E. Lee, J. Yu, H. Funahashi, T. Williams, M. Ferreira, V. Tang, R.A. McGovern, CD. Kenny, L.M. Christiansen, E. Edelstein, B. Choi, O. Boss, C. Aschkenasi, C.Y. Zhang, K. Mountjoy, T. Kishi, J.K. Elmquist, and B.B. Lowell, Divergence of melanocortin pathways in the control of food intake and energy expenditure. Cell 123 (2005) 493-505.
37. I.S. Farooqi, J.M. Keogh, G.S. Yeo, E.J. Lank, T. Cheetham, and S. O'Rahilly, Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med 348 (2003) 1085-95.
38. R.J. Loos, CM. Lindgren, S. Li, E. Wheeler, J.H. Zhao, I. Prokopenko, M. Inouye, R.M. Freathy, A.P. Attwood, J.S. Beckmann, S.I. Berndt, K.B. Jacobs, S.J. Chanock, R.B. Hayes, S. Bergmann, A.J. Bennett, S.A. Bingham, M. Bochud, M. Brown, S. Cauchi, J.M. Connell, C. Cooper, G.D. Smith, I. Day, C. Dina, S. De, E.T. Dermitzakis, A.S. Doney, K.S. Elliott, P. Elliott, D.M. Evans, I. Sadaf Farooqi, P. Froguel, J. Ghori, C.J. Groves, R. Gwilliam, D. Hadley, A.S. Hall, A.T. Hattersley, J. Hebebrand, I.M. Heid, C. Lamina, C. Gieger, T. Illig, T. Meitinger, H.E. Wichmann, B. Herrera, A. Hinney, S.E. Hunt, M.R. Jarvelin, T. Johnson, J.D. Jolley, F. Karpe, A. Keniry, K.T. Khaw, R.N. Luben, M. Mangino, J. Marchini, W.L. McArdle, R. McGinnis, D. Meyre, P.B. Munroe, A.D. Morris, A.R. Ness, M.J. Neville, A.C. Nica, K.K. Ong, S. O'Rahilly, K.R. Owen, C.N. Palmer, K. Papadakis, S. Potter, A. Pouta, L. Qi, J.C. Randall, N.W. Rayner, S.M. Ring, M.S. Sandhu, A. Scherag, M.A. Sims, K. Song, N. Soranzo, E.K. Speliotes, H.E. Syddall, S.A. Teichmann, N.J. Timpson, J.H. Tobias, M. Uda, CI. Vogel, C. Wallace, D.M. Waterworth, M.N. Weedon, C.J. Willer, Wraight, X. Yuan, E. Zeggini, J.N. Hirschhorn, D.P. Strachan, W.H. Ouwehand, M.J. Caulfield, et al., Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet 40 (2008) 768-75.
39. J.C. Chambers, P. Elliott, D. Zabaneh, W. Zhang, Y. Li, P. Froguel, D. Balding, J. Scott, and J.S. Kooner, Common genetic variation near MC4R is associated with waist circumference and insulin resistance. Nat Genet 40 (2008) 716-8.
40. E.D. Berglund, T. Liu, X. Kong, J.W. Sohn, L. Vong, Z. Deng, C.E. Lee, S. Lee, K.W. Williams, D.P. Olson, P.E. Scherer, B.B. Lowell, and J.K. Elmquist, Melanocortin 4 receptors in autonomic neurons regulate thermogenesis and glycemia. Nat Neurosci 17 (2014) 911-3.
41. J.W. Sohn, L.E. Harris, E.D. Berglund, T. Liu, L. Vong, B.B. Lowell, N. Balthasar, K.W. Williams, and J.K. Elmquist, Melanocortin 4 receptors reciprocally regulate sympathetic and parasympathetic preganglionic neurons. Cell 152 (2013) 612-9.
42. B.K. Lim, K.W. Huang, B.A. Grueter, P.E. Rothwell, and R.C. Malenka, Anhedonia requires MC4R-mediated synaptic adaptations in nucleus accumbens. Nature 487 (2012) 183-9.
43. L.H. Van der Ploeg, W.J. Martin, A.D. Howard, R.P. Nargund, C.P. Austin, X. Guan, J. Drisko, D. Cashen, I. Sebhat, A.A. Patchett, D.J. Figueroa, A.G. DiLella, B.M. Connolly, D.H. Weinberg, C.P. Tan, O.C. Palyha, S.S. Pong, T. MacNeil, C. Rosenblum, A. Vongs, R. Tang, H. Yu, A.W. Sailer, T.M. Fong, C. Huang, M.R. Tota, R.S. Chang, R. Stearns, C. Tamvakopoulos, G. Christ, D.L. Drazen, B.D. Spar, R.J. Nelson, and D.E. MacIntyre, A role for the melanocortin 4 receptor in sexual function. Proc Natl Acad Sci U S A 99 (2002) 11381-6.
44. B.L. Panaro, I.R. Tough, M.S. Engelstoft, R.T. Matthews, G.J. Digby, C.L. Moller, B. Svendsen, F. Gribble, F. Reimann, J.J. Holst, B. Holst, T.W. Schwartz, H.M. Cox, and R.D. Cone, The Melanocortin-4 Receptor Is Expressed in Enteroendocrine L Cells and Regulates the Release of Peptide YY and Glucagon-like Peptide 1 In Vivo. Cell Metab 20 (2014) 1018-29.
45. W. Chen, M.A. Kelly, X. Opitz-Araya, R.E. Thomas, M.J. Low, and R.D. Cone, Exocrine gland dysfunction in MC5-R-deficient mice: evidence for coordinated regulation of exocrine gland function by melanocortin peptides. Cell 91 (1997) 789-98.
46. M. van der Kraan, R.A. Adan, M.L. Entwistle, W.H. Gispen, J.P. Burbach, and J.B. Tatro, Expression of melanocortin-5 receptor in secretory epithelia supports a functional role in exocrine and endocrine glands. Endocrinology 139 (1998) 2348-55.
47. G.P. Vinson, B.J. Whitehouse, A. Dell, T. Etienne, and H.R. Morris, Characterisation of an adrenal zona glomerulosa-stimulating component of posterior pituitary extracts as alpha-MSH. Nature 284 (1980) 464-7.
48. N. Griffon, V. Mignon, P. Facchinetti, J. Diaz, J.C. Schwartz, and P. Sokoloff, Molecular cloning and characterization of the rat fifth melanocortin receptor. Biochem Biophys Res Commun 200(1994)1007-14.
49. A.R. Rodrigues, H. Almeida, and A.M. Gouveia, Alpha-MSH signalling via melanocortin 5 receptor promotes lipolysis and impairs re-esterification in adipocytes. Biochim Biophys Acta 1831 (2013) 1267-75.
50. L.A. Metherell, J.P. Chapple, S. Cooray, A. David, C. Becker, F. Ruschendorf, D. Naville, M. Begeot, B. Khoo, P. Nurnberg, A. Huebner, M.E. Cheetham, and A.J. Clark, Mutations in MRAP, encoding a new interacting partner of the ACTH receptor, cause familial glucocorticoid deficiency type 2. Nat Genet 37 (2005) 166-70.
51. L.F. Chan, T.R. Webb, T.T. Chung, E. Meimaridou, S.N. Cooray, L. Guasti, J.P. Chapple, M. Egertova, M.R. Elphick, M.E. Cheetham, L.A. Metherell, and A.J. Clark, MRAP and MRAP2 are bidirectional regulators of the melanocortin receptor family. Proc Natl Acad Sci U S A 106 (2009) 6146-51.
52. L.A. Noon, J.M. Franklin, P.J. King, N.J. Goulding, L. Hunyady, and A.J. Clark, Failed export of the adrenocorticotrophin receptor from the endoplasmic reticulum in non-adrenal cells: evidence in support of a requirement for a specific adrenal accessory factor. J Endocrinol 174 (2002) 17-25.
53. A. Xu, K.L. Choi, Y. Wang, P.A. Permana, L.Y. Xu, C. Bogardus, and G.J. Cooper, Identification of novel putative membrane proteins selectively expressed during adipose conversion of 3T3-L1 cells. Biochem Biophys Res Commun 293 (2002) 1161-7.
54. T.R. Webb, and A.J. Clark, Minireview: the melanocortin 2 receptor accessory proteins. Mol Endocrinol 24 (2010) 475-84.
55. J.A. Sebag, and P.M. Hinkle, Melanocortin-2 receptor accessory protein MRAP forms antiparallel homodimers. Proc Natl Acad Sci U S A 104 (2007) 20244-9.
56. S.N. Cooray, I. Almiro Do Vale, K.Y. Leung, T.R. Webb, J.P. Chapple, M. Egertova, M.E. Cheetham, M.R. Elphick, and A.J. Clark, The melanocortin 2 receptor accessory protein exists as a homodimer and is essential for the function of the melanocortin 2 receptor in the mouse y1 cell line. Endocrinology 149 (2008) 1935-41.
57. S. Roy, M. Rached, and N. Gallo-Payet, Differential regulation of the human adrenocorticotropin receptor [melanocortin-2 receptor (MC2R)] by human MC2R accessory protein isoforms alpha and beta in isogenic human embryonic kidney 293 cells. Mol Endocrinol 21 (2007) 1656-69.
58. P.M. Hinkle, and J.A. Sebag, Structure and function of the melanocortin2 receptor accessory protein (MRAP). Mol Cell Endocrinol 300 (2009) 25-31.
59. M. Asai, S. Ramachandrappa, M. Joachim, Y. Shen, R. Zhang, N. Nuthalapati, V. Ramanathan, D.E. Strochlic, P. Ferket, K. Linhart, C. Ho, T.V. Novoselova, S. Garg, M. Ridderstrale, C. Marcus, J.N. Hirschhorn, J.M. Keogh, S. O'Rahilly, L.F. Chan, A.J. Clark, I.S. Farooqi, and J.A. Majzoub, Loss of function of the melanocortin 2 receptor accessory protein 2 is associated with mammalian obesity. Science 341 (2013) 275-8.
60. M.J. Agulleiro, S. Roy, E. Sanchez, S. Puchol, N. Gallo-Payet, and J.M. Cerda-Reverter, Role of melanocortin receptor accessory proteins in the function of zebrafish melanocortin receptor type 2. Mol Cell Endocrinol 320 (2010) 145-52.
61. J.A. Sebag, C. Zhang, P.M. Hinkle, A.M. Bradshaw, and R.D. Cone, Developmental control of the melanocortin-4 receptor by MRAP2 proteins in zebrafish. Science 341 (2013) 278-81.
62. R.M. Dores, Observations on the evolution of the melanocortin receptor gene family: distinctive features of the melanocortin-2 receptor. Front Neurosci 7 (2013) 28.
63. K. Gardiner, D. Slavov, L. Bechtel, and M. Davisson, Annotation of human chromosome 21 for relevance to Down syndrome: gene structure and expression analysis. Genomics 79 (2002) 833-43.
64. S. Hu, G. Yao, Y. Wang, H. Xu, X. Ji, Y. He, Q. Zhu, Z. Chen, and Y. Sun, Transcriptomic changes during the pre-receptive to receptive transition in human endometrium detected by RNASeq. J Clin Endocrinol Metab (2014) jc20142155.
65. S. Roy, B. Perron, and N. Gallo-Payet, Role of asparagine-linked glycosylation in cell surface expression and function of the human adrenocorticotropin receptor (melanocortin 2 receptor) in 293/FRT cells. Endocrinology 151 (2010) 660-70.
66. E.I. Kay, R. Botha, J.M. Montgomery, and K.G. Mountjoy, hMRAPa specifically alters hMC4R molecular mass and N-linked complex glycosylation in HEK293 cells. J Mol Endocrinol 50 (2013) 217-27.
67. R.J. Gorrigan, L. Guasti, P. King, A.J. Clark, and L.F. Chan, Localisation of the melanocortin-2-receptor and its accessory proteins in the developing and adult adrenal gland. J Mol Endocrinol 46 (2011) 227-32.
68. J.A. Sebag, and P.M. Hinkle, Regulation of G protein-coupled receptor signaling: specific dominant-negative effects of melanocortin 2 receptor accessory protein 2. Sci Signal 3 (2010)ra28.
69. J.A. Sebag, and P.M. Hinkle, Opposite effects of the melanocortin-2 (MC2) receptor accessory protein MRAP on MC2 and MC5 receptor dimerization and trafficking. J Biol Chem 284 (2009) 22641-8.
70. E.I. Kay, R. Botha, J.M. Montgomery, and K.G. Mountjoy, hMRAPa increases alphaMSHinduced hMC1R and hMC3R functional coupling and hMC4R constitutive activity. J Mol Endocrinol 50 (2013) 203-15.
71. T.T. Chung, L.F. Chan, L.A. Metherell, and A.J. Clark, Phenotypic characteristics of familial glucocorticoid deficiency (FGD) type 1 and 2. Clin Endocrinol (Oxf) 72 (2010) 589-94.
72. C.R. Hughes, T.T. Chung, A.M. Habeb, F. Kelestimur, A.J. Clark, and L.A. Metherell, Missense mutations in the melanocortin 2 receptor accessory protein that lead to late onset familial glucocorticoid deficiency type 2. J Clin Endocrinol Metab 95 (2010) 3497-501.
73. A.J. Clark, and A. Weber, Adrenocorticotropin insensitivity syndromes. Endocr Rev 19 (1998) 828-43.
74. H. Liu, T. Kishi, A.G. Roseberry, X. Cai, C.E. Lee, J.M. Montez, J.M. Friedman, and J.K. Elmquist, Transgenic mice expressing green fluorescent protein under the control of the melanocortin-4 receptor promoter. J Neurosci 23 (2003) 7143-54.
75. J. Hofland, P.J. Delhanty, J. Steenbergen, L.J. Hofland, P.M. van Koetsveld, F.H. van Nederveen, W.W. de Herder, R.A. Feelders, and F.H. de Jong, Melanocortin 2 receptorassociated protein (MRAP) and MRAP2 in human adrenocortical tissues: regulation of expression and association with ACTH responsiveness. J Clin Endocrinol Metab 97 (2012) E747-54.
76. G.M. Sutton, J.L. Trevaskis, M.W. Hulver, R.P. McMillan, N.J. Markward, M.J. Babin, E.A. Meyer, and A.A. Butler, Diet-genotype interactions in the development of the obese, insulin-resistant phenotype of C57BL/6J mice lacking melanocortin-3 or -4 receptors. Endocrinology 147 (2006) 2183-96.
77. C. Vaisse, K. Clement, B. Guy-Grand, and P. Froguel, A frameshift mutation in human MC4R is associated with a dominant form of obesity. Nat Genet 20 (1998) 113-4.
78. G.S. Yeo, I.S. Farooqi, S. Aminian, D.J. Halsall, R.G. Stanhope, and S. O'Rahilly, A frameshift mutation in MC4R associated with dominantly inherited human obesity. Nat Genet 20 (1998)111-2.
79. A.S. Chen, D.J. Marsh, M.E. Trumbauer, E.G. Frazier, X.M. Guan, H. Yu, C.I. Rosenblum, A. Vongs, Y. Feng, L. Cao, J.M. Metzger, A.M. Strack, R.E. Camacho, T.N. Mellin, C.N. Nunes, W. Min, J. Fisher, S. Gopal-Truter, D.E. MacIntyre, H.Y. Chen, and L.H. Van der Ploeg, Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat Genet 26 (2000) 97-102.
80. J. Park, N. Sharma, and G.R. Cutting, Melanocortin 3 receptor has a 5' exon that directs translation of apically localized protein from the second in-frame ATG. Mol Endocrinol 28 (2014) 1547-57.
81. H. Rumie, L.A. Metherell, A.J. Clark, V. Beauloye, and M. Maes, Clinical and biological phenotype of a patient with familial glucocorticoid deficiency type 2 caused by a mutation of melanocortin 2 receptor accessory protein. Eur J Endocrinol 157 (2007) 539-42.
82. N.S. Kim, Y.J. Kim, S.Y. Cho, T.R. Lee, and S.H. Kim, Transcriptional activation of melanocortin 2 receptor accessory protein by PPARgamma in adipocytes. Biochem Biophys Res Commun 439 (2013) 401-6.
83. P. Tontonoz, E. Hu, and B.M. Spiegelman, Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 79 (1994) 1147-56.
84. E. Bouw, M. Huisman, S.J. Neggers, A.P. Themmen, A.J. van der Lely, and P.J. Delhanty, Development of potent selective competitive-antagonists of the melanocortin type 2 receptor. Mol Cell Endocrinol 394 (2014) 99-104.
85. D.J. MacNeil, A.D. Howard, X. Guan, T.M. Fong, R.P. Nargund, M.A. Bednarek, M.T. Goulet, D.H. Weinberg, A.M. Strack, D.J. Marsh, H.Y. Chen, C.P. Shen, A.S. Chen, C.I. Rosenblum, T. MacNeil, M. Tota, E.D. MacIntyre, and L.H. Van der Ploeg, The role of melanocortins in body weight regulation: opportunities for the treatment of obesity. Eur J Pharmacol 450 (2002) 93-109.
86. L.L. Kiefer, O.R. Ittoop, K. Bunce, A.T. Truesdale, D.H. Willard, J.S. Nichols, S.G. Blanchard, K. Mountjoy, W.J. Chen, and W.O. Wilkison, Mutations in the carboxyl terminus of the agouti protein decrease agouti inhibition of ligand binding to the melanocortin receptors. Biochemistry 36 (1997) 2084-90.